Advancing a targeted approach to treat GRIN-related disorders and other pediatric neurodevelopmental disorders.
GRIN Therapeutics, Inc. is dedicated to advancing a targeted approach to treat GRIN-related disorders and other pediatric neurodevelopmental disorders. Recognizing the significant unmet needs in healthcare related to neurodevelopmental disorders, GRIN Therapeutics, Inc. focuses on research and development to bring hope to patients and caregivers affected by these conditions. The company is committed to developing precision therapeutics for pediatric neurodevelopmental disorders. The primary address for GRIN Therapeutics, Inc. is New York, NY, US.
GRIN Therapeutics, Inc. specializes in a range of critical areas including healthcare, drug development, central nervous system research, and the treatment of neurodevelopmental disorders. Through clinical studies, GRIN Therapeutics, Inc. aims to address neurodegenerative conditions, rare diseases, and other life science challenges. With a focus on clinical research, the company targets pediatric epilepsy, seizure disorders, and other rare disorders, contributing significantly to clinical development and neuroscience.
GRIN Therapeutics, Inc. is deeply involved in pharmaceuticals, precision therapeutics, patient advocacy, and epilepsy research. The company's mission is to improve the lives of those affected by pediatric neurodevelopmental disorders. We invite the management of GRIN Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.
Compare GRIN Therapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
GRIN Therapeutics, Inc.Main Company |
NIHR (National Insti...View Profile |
Castle Creek Bioscie...View Profile |
Center for Healthcar...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2006 | 2020 | 2009 |
|
Company Size
|
— | 10,001+ | 11-50 | 2-10 |
|
City
|
New York, NY | Exton, Pennsylvania | Chicago, Illinois | |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
26 Total Skills
Biotechnology
Neurodevelopmental Disorders
Precision Therapeutics
Drug Development
Clinical Research
Pediatric Epilepsy
Central Nervous System
Healthcare
Drug development
Central nervous system
Neurodevelopmental disorders
Clinical study
Neurodegenerative
Rare diseases
Life sciences
Clinical research
Pediatric epilepsy
Seizure
Research
Rare disorders
Clinical development
Neuroscience
Pharmaceuticals
Precision therapeutics
Patient advocacy
Epilepsy
|
11 Total
11 Unique
Unique Skills:
Applied research
clinical trials
Health research
Innovation
Medical research
Medicine
+5
|
9 Total
9 Unique
Unique Skills:
Bioscience
Dermatology
Epidermolysis Bullosa
Gene therapy
Genetics
Orphan drug
+3
|
10 Total
10 Unique
Unique Skills:
Clinical Trials
Data Analytics
Diversity & Inclusion
Education
Health Disparities
Health Inequities
+4
|
Other organizations in the same industry
This company is also known as